HomeI9DN • FRA
add
Arbutus Biopharma Corp
Nakaraang pagsara
€2.86
Sakop ng araw
€2.92 - €2.92
Sakop ng taon
€2.45 - €4.22
Market cap
679.75M USD
Average na Volume
259.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.57M | -26.62% |
Gastos sa pagpapatakbo | 8.43M | 65.30% |
Net na kita | -12.53M | 35.11% |
Net profit margin | -796.19 | 11.57% |
Kita sa bawat share | -0.10 | 38.71% |
EBITDA | -15.34M | 23.94% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 122.62M | -2.68% |
Kabuuang asset | 131.71M | -8.79% |
Kabuuang sagutin | 34.34M | -10.53% |
Kabuuang equity | 97.37M | — |
Natitirang share | 191.48M | — |
Presyo para makapag-book | 5.61 | — |
Return on assets | -28.79% | — |
Return on capital | -36.08% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -12.53M | 35.11% |
Cash mula sa mga operasyon | -10.32M | 40.35% |
Cash mula sa pag-invest | 13.41M | -39.66% |
Cash mula sa financing | 1.42M | -62.67% |
Net change in cash | 4.48M | -48.78% |
Malayang cash flow | -10.96M | -18.93% |
Tungkol
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Itinatag
2007
Headquarters
Website
Mga Empleyado
44
